These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study. Weder AB; Delgado MC; Zhu X; Gleiberman L; Kan D; Chakravarti A Hypertension; 2003 Mar; 41(3 Pt 2):842-6. PubMed ID: 12624006 [TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms and erythrocyte sodium-lithium countertransport in essential hypertension. Tournoy KG; Delanghe JR; Duprez DA; De Buyzere ML; Verbeeck RM; Vergauwe DA; Leroux-Roels GG; Clement DL Clin Chim Acta; 1996 Nov; 255(1):39-55. PubMed ID: 8930412 [TBL] [Abstract][Full Text] [Related]
10. Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Weder AB; Schork NJ; Julius S Hypertension; 1991 Jun; 17(6 Pt 2):977-81. PubMed ID: 2045179 [TBL] [Abstract][Full Text] [Related]
11. A Systematic single nucleotide polymorphism screen to fine-map alcohol dependence genes on chromosome 7 identifies association with a novel susceptibility gene ACN9. Dick DM; Aliev F; Wang JC; Saccone S; Hinrichs A; Bertelsen S; Budde J; Saccone N; Foroud T; Nurnberger J; Xuei X; Conneally PM; Schuckit M; Almasy L; Crowe R; Kuperman S; Kramer J; Tischfield JA; Hesselbrock V; Edenberg HJ; Porjesz B; Rice JP; Bierut L; Goate A Biol Psychiatry; 2008 Jun; 63(11):1047-53. PubMed ID: 18163977 [TBL] [Abstract][Full Text] [Related]
12. Exclusion of the Na(+)-H+ antiporter as a candidate gene in human essential hypertension. Lifton RP; Hunt SC; Williams RR; Pouysségur J; Lalouel JM Hypertension; 1991 Jan; 17(1):8-14. PubMed ID: 1846121 [TBL] [Abstract][Full Text] [Related]
13. Assessing the role of APNH, a gene encoding for a human amiloride-sensitive Na+/H+ antiporter, on the interindividual variation in red cell Na+/Li+ countertransport. Dudley CR; Giuffra LA; Raine AE; Reeders ST J Am Soc Nephrol; 1991 Oct; 2(4):937-43. PubMed ID: 1661190 [TBL] [Abstract][Full Text] [Related]
14. Influence of Silva LVCD; Javorski N; André Cavalcanti Brandão L; Lima MC; Crovella S; Eickmann SH J Matern Fetal Neonatal Med; 2020 Jan; 33(1):127-135. PubMed ID: 29886784 [No Abstract] [Full Text] [Related]
15. Higher urinary albumin excretion is associated with abnormal erythrocyte Na(+)/Li(+) countertransport (SLC) in non-modulating essential hypertensives and offspring of hypertensive parents. Sánchez RA; Giannone C; Masnatta LD; Baglivo HP; Ramírez AJ J Hum Hypertens; 2002 Mar; 16 Suppl 1():S128-32. PubMed ID: 11986910 [TBL] [Abstract][Full Text] [Related]
17. Mapping of a blood pressure QTL on chromosome 17 in American Indians of the strong heart family study. Franceschini N; Tao R; Liu L; Rutherford S; Haack K; Almasy L; Göring HH; Laston S; Lee ET; Best LG; Fabsitz R; Cole SA; North KE BMC Cardiovasc Disord; 2014 Nov; 14():158. PubMed ID: 25387527 [TBL] [Abstract][Full Text] [Related]
19. Sulphydryl group control of sodium-lithium countertransport kinetics: a membrane protein control abnormality in essential hypertension. Thomas TH; Rutherford PA; West IC; Wilkinson R Eur J Clin Invest; 1995 Apr; 25(4):235-40. PubMed ID: 7601199 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension. Hardman TC; Wierzbicki AS; Croft P; Feher M; Cox A; Lant AF J Hum Hypertens; 1996 Jun; 10(6):429-30. PubMed ID: 8872813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]